LIVZON PHARMA (01513): Independent director candidate Wang Zhiyao obtains Shenzhen Stock Exchange Independent Director Training Certification.

LIVZON PHARMA (01513) announced that the board of directors held the 28th meeting of the 11th session on November 10, 2025, and approved the proposal to nominate Ms. Wang Zhiyao as a candidate for independent non-executive director. Ms. Wang Zhiyao (Ms. Wang) was nominated as a candidate for independent non-executive director of the 11th Board of Directors. This proposal still needs to be submitted to the company's shareholders' meeting for approval, with a term from the date of approval by the shareholders' meeting until the completion of the term of the 11th Board of Directors. As of the date of the notice of the first extraordinary general meeting of shareholders in 2025, Ms. Wang has not obtained the certificate of independent director training. In accordance with the relevant regulations of the Shenzhen Stock Exchange, Ms. Wang has made a written commitment to attend the most recent training session for independent directors and obtain the certificate recognized by the Shenzhen Stock Exchange for training of independent directors of listed companies. Recently, the company received a notification from Ms. Wang that she has attended the most recent training session for independent directors (online) and obtained the certificate recognized by the Shenzhen Stock Exchange for training of independent directors of listed companies. In addition, the qualifications and independence of the independent director candidate have been reviewed and approved by the Shenzhen Stock Exchange.